Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study (vol 31, pg 921, 2020)

Affiliation auteurs!!!! Error affiliation !!!!
TitrePrognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study (vol 31, pg 921, 2020)
Type de publicationJournal Article
Year of Publication2020
AuteursPages F., Andre T., Taieb J., Vernerey D., Henriques J., Borg C., Marliot F., Ben Jannet R., Louvet C., Mineur L., Bennouna J., Desrame J., Faroux R., Kirilovsky A., Duval A., Laurent-Puig P., Svrcek M., Hermitte F., Catteau A., Galon J., Emile J-F
JournalANNALS OF ONCOLOGY
Volume31
Pagination1276
Date PublishedSEP
Type of ArticleCorrection
ISSN0923-7534
DOI10.1016/j.annonc.2020.06.013